Insider trades

Diana Brainard, Director of Nektar Therapeutics NKTR, has filed 0 purchases and 31 sales on the open market. The latest trade was on 09/23.

Diana Brainard

Director
First filing
23/01/23
Trades
37 trades
Buys / sales
0 / 31
12-month net buying
No record
Last trade
09/23

Trading activity

Transactions

Trade type
Open-market sale24/11/1924/11/208,706 sh$0.55$4,788.3−1.2%
Open-market sale24/11/0524/11/0610,609 sh$0.86$9,123.74−1.4%
Open-market sale24/10/2124/10/239,752 sh$0.78$7,606.56−1.3%
Open-market sale24/10/0324/10/041,493 sh$0.81$1,209.33−0.2%
Open-market sale24/08/2024/08/225,390 sh$0.74$3,988.6−0.7%
Open-market sale24/08/1924/08/203,091 sh$0.76$2,349.16−0.4%
Open-market sale24/08/0524/08/0710,847 sh$0.73$7,918.31−1.4%
Open-market sale24/07/1924/07/239,731 sh$0.75$7,298.25−1.2%
Open-market sale24/07/0224/07/031,489 sh$0.72$1,072.08−0.2%
Open-market sale24/05/2124/05/235,149 sh$0.79$4,067.71−0.7%
Open-market sale24/05/1724/05/213,075 sh$0.75$2,306.25−0.4%
Open-market sale24/05/0324/05/0710,240 sh$0.80$8,192−1.3%
Open-market sale24/04/1924/04/239,601 sh$0.75$7,200.75−1.2%
Open-market sale24/04/0224/04/041,533 sh$0.77$1,180.41−0.2%
KLRS
Open-market sale24/02/20–24/02/2124/02/228,252 sh2 trades$0.71avg.$5,827.95−1.0%
Open-market sale24/02/0524/02/0641,421 sh$0.67$27,752.07−4.8%
Open-market sale24/01/2324/01/259,500 sh$0.67$6,365−1.1%
Open-market sale24/01/0424/01/081,664 sh$0.64$1,064.96−0.2%
KLRS
Open-market sale10b5-1 plan23/11/17–23/11/2023/11/217,071 sh2 trades$1.67avg.$11,788.65−0.8%
Open-market sale10b5-1 plan23/10/1923/10/238,581 sh$1.58$13,557.98−1.0%